Overview Financials News + Filings Key Docs Ownership Insiders
|
Tarsus Pharmaceuticals, Inc.
|
|
Credit Analysis |
|
|
|
|
Annual | Quarterly |
|
In millions, except per share items | Jun-30-23 | Mar-31-23 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| Source | Source | Source | Source | Source | Source | Source | Source |
Long-term debt | 24.6 | 24.5 | 19.4 | 19.3 | 19.2 | | | |
Total debt | 24.6 | 24.5 | 19.4 | 19.3 | 19.2 | | | |
|
Debt to EBITDA | | | | | | | | 0.0 |
|
|